Extensive clinical testing would be needed to draw conclusions about the safety
of TOFA and C75, or similar compounds, as antiviral treatment. That said, the
team took an early look at toxicity, exposing uninfected fibroblasts to C75 or
TOFA for 96 hours. They found that the drugs blocked HCMV replication without
causing cell toxicity or self-destruction (apoptosis). …
“Our results suggest the genetic make-up of patients could predispose their
responsiveness to a drug. This could have important implications for the future
of personalized molecular-based or individualized medicine,” …
Statistics show ZERO improvement in lifespan or quality of life for about 98% of
patients receiving chemotherapy. Only a very small number of people suffering
rare forms of cancer have any documented benefits from the often-deadly
procedure. …
The charges would appear serious – the FDA says the drugmakers variously omitted
material facts; miminized important risks; overstated efficacy or made
unsubstantiated claims. …
Nikola Tesla stands as a poster boy for inventors, scientists, doctors and
educators of all kinds whose ideas and life’s work is dismissed because it is
found to be too beneficial to mankind, and not lucrative enough for big
business. …
The resulting isothermal RCA-LAMP reaction increases speed significantly over
the comparable hyperbranching method and improves convenience for field
applications where thermal cycling may be difficult. …
“I don’t think what’s being announced will protect humans and the environment from all the potential risks that a genetically engineered animal may pose,” said Jaffe of the Center for Science in the Public Interest [and he’s avidly pro-GM!]
Families in Argentina are saying GlaxoSmithKline tricked them into participating
in an experimental vaccine trial by telling them their children were receiving
medical treatment …
“Regardless of the cause, publication bias harms the public good by impairing
the ability of clinicians and patients to make informed clinical decisions, and
the ability of scientists to design safer and more efficient trials based on
past findings,” the authors wrote. “Publication bias can thus be considered a
form of scientific misconduct.” …
“Our findings indicate that each year, reasonably healthy women spend billions
of dollars on drugs in the hope of preventing heart attacks, but that scientific
evidence supporting their hope does not exist,” …